Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) Cash from Operations (2012 - 2026)

Updated

Phibro Animal Health (PAHC) posted Cash from Operations of $26.08 million for fiscal Q1 2027 (quarter ended Sep 30, 2026), up 180.4% from $9.3 million a year earlier and up 8.3% from the prior quarter.

Analysis

Phibro Animal Health (PAHC) Cash from Operations (2012 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Cash from Operations at Phibro Animal Health was $95.61 million, up 122.6% year-over-year; for FY2026 (ended Jun 30, 2026), it came in at $68.95 million, down 13.9% from FY2025.

  • Annual Cash from Operations shows a five-year compound annual growth rate of 7.4% (FY2021 to FY2026).
  • In prior fiscal years, Phibro Animal Health's Cash from Operations was $80.12 million in FY2025 (-8.5%), $87.59 million in FY2024 (+83.4%), $47.76 million in FY2023 (+50.9%) and $31.65 million in FY2022 (-34.5%).
  • Quarterly Cash from Operations has run from a low of -$10.7 million in fiscal Q3 2022 to a high of $31.56 million in fiscal Q2 2024 over five years.
  • On a year-over-year basis, Cash from Operations has increased in each of the last four quarters, with growth averaging 91.9% over the last eight quarters.
  • The strongest year-over-year quarter for Cash from Operations in the past five years was fiscal Q2 2026, with growth of 529.1%; the weakest was fiscal Q2 2025, with a decline of 90.3%.
  • According to Business Quant data, Cash from Operations for the three prior fiscal quarters was $24.09 million (Q4 2026), $26.08 million (Q3 2026) and $19.35 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 11.40 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 7.72 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 7.61 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 6.56 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.67 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 4.24 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 5.04 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 5.38 Bn
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 26.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 26.08 Mn
Jun 30, 2026 24.09 Mn
Mar 31, 2026 26.08 Mn
Dec 31, 2025 19.35 Mn
Sep 30, 2025 9.30 Mn
Jun 30, 2025 21.27 Mn
Mar 31, 2025 9.30 Mn
Dec 31, 2024 3.08 Mn
Sep 30, 2024 12.62 Mn
Jun 30, 2024 28.43 Mn
Mar 31, 2024 12.62 Mn
Dec 31, 2023 31.56 Mn
Sep 30, 2023 16.20 Mn
Jun 30, 2023 20.24 Mn
Mar 31, 2023 16.20 Mn
Dec 31, 2022 -2.49 Mn
Sep 30, 2022 -10.70 Mn
Jun 30, 2022 1.57 Mn
Mar 31, 2022 -10.70 Mn
Dec 31, 2021 20.12 Mn
API Access

Phibro Animal Health Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=PAHC&period=max&api_key=YOUR_API_KEY